Prometheus Biosciences, Inc. Quarterly Operating Margin in % from Q4 2020 to Q1 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Prometheus Biosciences, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q1 2023.
  • Prometheus Biosciences, Inc. Operating Margin for the quarter ending March 31, 2023 was -4.06K %, a 137% decline year-over-year.
  • Prometheus Biosciences, Inc. annual Operating Margin for 2022 was -2.14K %, a 23.7% increase from 2021.
  • Prometheus Biosciences, Inc. annual Operating Margin for 2021 was -2.81K %, a 18.9% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2023 -4.06K -2.35K -137% Jan 1, 2023 Mar 31, 2023
Q4 2022 -2.14K +665 +23.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -1.87K +731 +28.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -1.7K +770 +31.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -1.71K +264 +13.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -2.81K -446 -18.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -2.6K Jul 1, 2021 Sep 30, 2021
Q2 2021 -2.47K Apr 1, 2021 Jun 30, 2021
Q1 2021 -1.98K Jan 1, 2021 Mar 31, 2021
Q4 2020 -2.36K Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.